Design and validation of a semi-quantitative microneutralization assay for human Metapneumovirus A1 and B1 subtypes
Abstract Since 2001, human Metapneumovirus has been a significant cause of human respiratory disease worldwide, and no vaccine or preventive treatment is currently available. The ELISA-based live virus microneutralization assay is a method to detect neutralizing antibodies against a target pathogen....
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Online Access: | https://doi.org/10.1038/s41598-025-96567-6 |
